Developing a species-specific genetic agent for treatment of skin defects in dogs

Gene therapy is important in veterinary medicine due to the current need for more species-specific drugs, because they have proven to prevent an allergic response to heterologous proteins and other problems with the recipient immunity. In this study, we developed species-specific genetically enginee...

Full description

Saved in:
Bibliographic Details
Main Authors: E.Yu. Zakirova, A.M. Aimaletdinov, N.M. Alexandrova, I.M. Ganiev, S.A. Sofronova, A.N. Valeeva, E.E. Garanina, A.A. Rizvanov
Format: Article
Language:English
Published: Kazan Federal University 2020-09-01
Series:Учёные записки Казанского университета: Серия Естественные науки
Subjects:
Online Access:https://kpfu.ru/uz-eng-ns-2020-3-3.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850032806309134336
author E.Yu. Zakirova
A.M. Aimaletdinov
N.M. Alexandrova
I.M. Ganiev
S.A. Sofronova
A.N. Valeeva
E.E. Garanina
A.A. Rizvanov
author_facet E.Yu. Zakirova
A.M. Aimaletdinov
N.M. Alexandrova
I.M. Ganiev
S.A. Sofronova
A.N. Valeeva
E.E. Garanina
A.A. Rizvanov
author_sort E.Yu. Zakirova
collection DOAJ
description Gene therapy is important in veterinary medicine due to the current need for more species-specific drugs, because they have proven to prevent an allergic response to heterologous proteins and other problems with the recipient immunity. In this study, we developed species-specific genetically engineered plasmid constructs based on the pBUDK – clVECF164 – clFGF2 plasmid DNA, all encoding genes of the canine vascular endothelial and fibroblast growth factors, which can be used to treat skin, muscle, and ligament injuries in dogs. In vitro studies of these constructs demonstrated that they induce angiogenesis in mesenchymal stem cells. In vivo studies of the plasmid DNA revealed stimulation of skin regeneration in rats and dogs without affecting the general state of animals. No complications were observed after the subcutaneous injection of the plasmid DNA. The results obtained offer a tremendous potential for further advance in veterinary medicine.
format Article
id doaj-art-e1b8e1c85e114d68b7b4ace668c092e7
institution DOAJ
issn 2542-064X
2500-218X
language English
publishDate 2020-09-01
publisher Kazan Federal University
record_format Article
series Учёные записки Казанского университета: Серия Естественные науки
spelling doaj-art-e1b8e1c85e114d68b7b4ace668c092e72025-08-20T02:58:30ZengKazan Federal UniversityУчёные записки Казанского университета: Серия Естественные науки2542-064X2500-218X2020-09-01162336138010.26907/2542-064X.2020.3.361-380Developing a species-specific genetic agent for treatment of skin defects in dogsE.Yu. Zakirova0A.M. Aimaletdinov1N.M. Alexandrova2I.M. Ganiev3S.A. Sofronova4A.N. Valeeva5E.E. Garanina6A.A. Rizvanov7Kazan Federal University, Kazan, 420008 RussiaKazan Federal University, Kazan, 420008 RussiaKazan Federal University, Kazan, 420008 RussiaKazan Federal University, Kazan, 420008 RussiaKazan Federal University, Kazan, 420008 RussiaKazan State Academy of Veterinary Medicine, Kazan, 420074 RussiaKazan Federal University, Kazan, 420008 RussiaKazan Federal University, Kazan, 420008 RussiaGene therapy is important in veterinary medicine due to the current need for more species-specific drugs, because they have proven to prevent an allergic response to heterologous proteins and other problems with the recipient immunity. In this study, we developed species-specific genetically engineered plasmid constructs based on the pBUDK – clVECF164 – clFGF2 plasmid DNA, all encoding genes of the canine vascular endothelial and fibroblast growth factors, which can be used to treat skin, muscle, and ligament injuries in dogs. In vitro studies of these constructs demonstrated that they induce angiogenesis in mesenchymal stem cells. In vivo studies of the plasmid DNA revealed stimulation of skin regeneration in rats and dogs without affecting the general state of animals. No complications were observed after the subcutaneous injection of the plasmid DNA. The results obtained offer a tremendous potential for further advance in veterinary medicine.https://kpfu.ru/uz-eng-ns-2020-3-3.htmlspecies-specific gene therapyvascular endothelial growth factorfibroblast growth factordogskin damage
spellingShingle E.Yu. Zakirova
A.M. Aimaletdinov
N.M. Alexandrova
I.M. Ganiev
S.A. Sofronova
A.N. Valeeva
E.E. Garanina
A.A. Rizvanov
Developing a species-specific genetic agent for treatment of skin defects in dogs
Учёные записки Казанского университета: Серия Естественные науки
species-specific gene therapy
vascular endothelial growth factor
fibroblast growth factor
dog
skin damage
title Developing a species-specific genetic agent for treatment of skin defects in dogs
title_full Developing a species-specific genetic agent for treatment of skin defects in dogs
title_fullStr Developing a species-specific genetic agent for treatment of skin defects in dogs
title_full_unstemmed Developing a species-specific genetic agent for treatment of skin defects in dogs
title_short Developing a species-specific genetic agent for treatment of skin defects in dogs
title_sort developing a species specific genetic agent for treatment of skin defects in dogs
topic species-specific gene therapy
vascular endothelial growth factor
fibroblast growth factor
dog
skin damage
url https://kpfu.ru/uz-eng-ns-2020-3-3.html
work_keys_str_mv AT eyuzakirova developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT amaimaletdinov developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT nmalexandrova developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT imganiev developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT sasofronova developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT anvaleeva developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT eegaranina developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs
AT aarizvanov developingaspeciesspecificgeneticagentfortreatmentofskindefectsindogs